Literature DB >> 7648394

Regulation of thymocyte development through CD3: functional dissociation between p56lck and CD3 sigma in early thymic selection.

C N Levelt1, P Mombaerts, B Wang, H Kohler, S Tonegawa, K Eichmann, C Terhorst.   

Abstract

We studied the extent of functional linkage between CD3 sigma and p56lck in pre-TCR-dependent thymocyte development. Differentiation of DN to DP cells was examined by treatment of RAG2/CD3 sigma and RAG1/p56lck double-deficient mice with anti-CD3 epsilon antibodies. The results suggest that CD3 sigma has no specific role in this maturation step, but may be important for amplification of signaling through the pre-TCR. In contrast, p56lck is the main protein tyrosine kinase associated with signaling through the pre-TCR-CD3 complex. In DP thymocytes, the Ca2+ response to anti-CD3 epsilon was totally abolished in CD3 sigma-I-but only reduced in p56lck-I-mice, and in vivo responses to anti-CD3 epsilon differed from one another. Thus, CD3 sigma and p56lck are functionally not tightly associated and their deficiencies cause distinct developmental defects.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7648394     DOI: 10.1016/1074-7613(95)90091-8

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  14 in total

1.  CD3-epsilon overexpressed in prothymocytes acts as an oncogene.

Authors:  B Wang; J She; M Salio; D Allen; E Lacy; N Lonberg; C Terhorst
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

Review 2.  Insights into T-cell development from studies using transgenic and knockout mice.

Authors:  M A Basson; R Zamoyska
Journal:  Mol Biotechnol       Date:  2001-05       Impact factor: 2.695

3.  Lack of evidence for aggregation-dependent enhancement of p56lck in the signal transduction upon major histocompatibility complex recognition by mature T cells.

Authors:  Koji Eshima; Harumi Suzuki; Nobukata Shinohara
Journal:  Immunology       Date:  2002-05       Impact factor: 7.397

4.  CTCF regulates cell cycle progression of alphabeta T cells in the thymus.

Authors:  Helen Heath; Claudia Ribeiro de Almeida; Frank Sleutels; Gemma Dingjan; Suzanne van de Nobelen; Iris Jonkers; Kam-Wing Ling; Joost Gribnau; Rainer Renkawitz; Frank Grosveld; Rudi W Hendriks; Niels Galjart
Journal:  EMBO J       Date:  2008-10-16       Impact factor: 11.598

5.  Dendritic cell immunization route determines integrin expression and lymphoid and nonlymphoid tissue distribution of CD8 T cells.

Authors:  Stacey L Sheasley-O'Neill; C Colin Brinkman; Andrew R Ferguson; Melanie C Dispenza; Victor H Engelhard
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

6.  Replacement of pre-T cell receptor signaling functions by the CD4 coreceptor.

Authors:  A M Norment; K A Forbush; N Nguyen; M Malissen; R M Perlmutter
Journal:  J Exp Med       Date:  1997-01-06       Impact factor: 14.307

7.  The CD3-gammadeltaepsilon and CD3-zeta/eta modules are each essential for allelic exclusion at the T cell receptor beta locus but are both dispensable for the initiation of V to (D)J recombination at the T cell receptor-beta, -gamma, and -delta loci.

Authors:  L Ardouin; J Ismaili; B Malissen; M Malissen
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

8.  T cell development in mice lacking all T cell receptor zeta family members (Zeta, eta, and FcepsilonRIgamma).

Authors:  E W Shores; M Ono; T Kawabe; C L Sommers; T Tran; K Lui; M C Udey; J Ravetch; P E Love
Journal:  J Exp Med       Date:  1998-04-06       Impact factor: 14.307

9.  Essential and partially overlapping role of CD3gamma and CD3delta for development of alphabeta and gammadelta T lymphocytes.

Authors:  B Wang; N Wang; M Salio; A Sharpe; D Allen; J She; C Terhorst
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

10.  Requirement of CD3 complex-associated signaling functions for expression of rearranged T cell receptor beta VDJ genes in early thymic development.

Authors:  A Würch; J Biro; A J Potocnik; I Falk; H Mossmann; K Eichmann
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.